Related Experiment Videos
DNA variation and the future of human genetics
1Hexagen, Cambridge, UK. alan.schafer@hexagen.co.uk
Nature Biotechnology
|February 3, 1998
Summary
Mapping complex multifactorial diseases requires advanced DNA marker technology. Identifying common DNA polymorphisms and high-throughput screening will unlock the genetic basis of common diseases.
Area of Science:
- Human Genetics
- Genomics
- Disease Etiology
Background:
- DNA variants are established tools for human genome mapping and monogenic disease gene identification.
- Multifactorial diseases, influenced by multiple genes and environmental factors, pose a significant genetic mapping challenge.
- Current genetic mapping technologies are insufficient for complex disease investigations.
Purpose of the Study:
- To outline the challenges and requirements for determining the genetic basis of multifactorial diseases.
- To highlight the necessity of advanced DNA marker technology and population screening methods.
- To propose a pathway for elucidating the genetic component of common phenotypes.
Main Methods:
- Leveraging established DNA variant analysis for genome mapping.
- Developing and applying high-throughput screening technologies.
- Systematic identification of common DNA polymorphisms across the human genome.
Main Results:
- The study identifies the need for extensive DNA markers and large-scale population screening.
- It emphasizes the potential of common DNA polymorphisms for genetic research.
- The development of high-throughput screening is crucial for progress.
Conclusions:
- Elucidating the genetic component of multifactorial diseases requires a combination of comprehensive DNA polymorphism identification and advanced screening technologies.
- This approach is essential for understanding the genetic underpinnings of both clinical and nonclinical phenotypes.
- Future research should focus on developing and implementing these technologies to overcome current challenges in complex disease genetics.